» Articles » PMID: 31828019

Metacognitive Function and Fragmentation in Schizophrenia: Relationship to Cognition, Self-experience and Developing Treatments

Overview
Specialty Psychology
Date 2019 Dec 13
PMID 31828019
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Bleuler suggested that fragmentation of thought, emotion and volition were the unifying feature of the disorders he termed schizophrenia. In this paper we review research seeking to measure some of the aspects of fragmentation related to the experience of the self and others described by Bleuler. We focus on work which uses the concept of metacognition to characterize and quantify alterations or decrements in the processes by which fragments or pieces of information are integrated into a coherent sense of self and others. We describe the rationale and support for one method for quantifying metacognition and its potential to study the fragmentation of a person's sense of themselves, others and the relative place of themselves and others in the larger human community. We summarize research using that method which suggests that deficits in metacognition commonly occur in schizophrenia and are related to basic neurobiological indices of brain functioning. We also present findings indicating that the capacity for metacognition in schizophrenia is positively related to a broad range of aspects of psychological and social functioning when measured concurrently and prospectively. Finally, we discuss the evolution and study of one therapy that targets metacognitive capacity, Metacognitive Reflection and Insight Therapy (MERIT) and its potential to treat fragmentation and promote recovery.

Citing Articles

Expressive Suppression of Emotions in Bulimia Nervosa: An Electroencephalography Study.

Desdentado L, Pollatos O J Clin Psychol. 2024; 81(3):158-170.

PMID: 39703155 PMC: 11802486. DOI: 10.1002/jclp.23761.


The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia.

Fekih-Romdhane F, Kerbage G, Hachem N, El Murr M, Haddad G, Loch A BMC Psychiatry. 2024; 24(1):831.

PMID: 39567927 PMC: 11577635. DOI: 10.1186/s12888-024-06275-0.


Clinical subtypes of schizophrenia based on the discrepancies between objective performance on social cognition tasks and subjective difficulties in social cognition.

Uchino T, Akiyama H, Okubo R, Wada I, Aoki A, Nohara M Schizophrenia (Heidelb). 2024; 10(1):94.

PMID: 39472633 PMC: 11522310. DOI: 10.1038/s41537-024-00515-8.


Community Mental Health Practice in the United States: Past, Present and Future.

Hamm J, Rutherford S, Wiesepape C, Lysaker P Consort Psychiatr. 2024; 1(2):7-13.

PMID: 39006900 PMC: 11240134. DOI: 10.17650/2712-7672-2020-1-2-7-13.


Subjective Experience and Perceived Benefits in Clients with Schizophrenia Following Participation in Metacognition Reflection and Insight Therapy (MERIT).

Tsuck-Ram N, Moka A, Lavi-Rotenberg A, Igra L, Hasson-Ohayon I Behav Sci (Basel). 2024; 14(6).

PMID: 38920781 PMC: 11200425. DOI: 10.3390/bs14060450.


References
1.
Inchausti F, Garcia-Poveda N, Ballesteros-Prados A, Fonseca-Pedrero E, Ortuno-Sierra J, Sanchez-Reales S . A pilot study on feasibility, acceptance and effectiveness of metacognitive-oriented social skills training in schizophrenia. BMC Psychiatry. 2017; 17(1):217. PMC: 5468977. DOI: 10.1186/s12888-017-1378-z. View

2.
Ladegaard N, Videbech P, Lysaker P, Larsen E . The course of social cognitive and metacognitive ability in depression: Deficit are only partially normalized after full remission of first episode major depression. Br J Clin Psychol. 2015; 55(3):269-86. DOI: 10.1111/bjc.12097. View

3.
Lysaker P, Dimaggio G . Metacognitive capacities for reflection in schizophrenia: implications for developing treatments. Schizophr Bull. 2014; 40(3):487-91. PMC: 3984530. DOI: 10.1093/schbul/sbu038. View

4.
Maatz A, Hoff P, Angst J . Eugen Bleuler's schizophrenia--a modern perspective. Dialogues Clin Neurosci. 2015; 17(1):43-9. PMC: 4421899. View

5.
Kukla M, Lysaker P, Roe D . Strong subjective recovery as a protective factor against the effects of positive symptoms on quality of life outcomes in schizophrenia. Compr Psychiatry. 2014; 55(6):1363-8. DOI: 10.1016/j.comppsych.2014.04.022. View